1. Targeted antibiotic management of ventilator-associated pneumonia
J.-Y. Fagon, J. Rello 
Clinical Microbiology and Infection 
Volume 12, Pages (January 2006)
DOI: /j x
Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions

2. Fig. 1
Clinical strategy applied to patients with clinical suspicion of ventilator-associated pneumonia (VAP). Reproduced with permission from Chastre & Fagon [1]. ATS, American Thoracic Society; IDSA, Infectious Diseases Society of America.
Clinical Microbiology and Infection  , 17-22DOI: ( /j x)
Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions

3. Fig. 2
Bacteriological strategy applied to patients with clinical suspicion of ventilator-associated pneumonia (VAP). Reproduced with permission from Chastre & Fagon [1]. ATS, American Thoracic Society; BAL, bronchoalveolar lavage; IDSA, Infectious Diseases Society of America; PSB, protected specimen brush.
Clinical Microbiology and Infection  , 17-22DOI: ( /j x)
Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions

4. Fig. 3
Flow diagram for guidance of initial management decisions for patients with suspected ventilator-associated pneumonia (VAP)—the ‘Tarragona approach’. Reproduced with permission from Vidaur et al. [7]. MRSA, methicillin-resistant Staphylococcus aureus
Clinical Microbiology and Infection  , 17-22DOI: ( /j x)
Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions

5. Fig. 4
Flow diagram for guidance of reassessment of patients with ventilator-associated pneumonia (VAP) after 48–72 h according to clinical response and microbiological cultures. Reproduced with permission from Rello & Diaz [5].
Clinical Microbiology and Infection  , 17-22DOI: ( /j x)
Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions